- EN
New EMCDDA products and services
New EMCDDA monograph focuses on harm reduction
EMCDDA Monograph No 10, entitled Harm reduction: evidence, impacts and challenges, was released in April ahead of a major international conference on the issue. Through 16 chapters, authored by over 50 European and international experts, the monograph provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion as part of the new public health movement of the mid-1980s. It explores the concept from several perspectives (e.g. international organisations, academic researchers and drug users). Part II is dedicated to current evidence and impacts of harm reduction and illustrates how the concept has broadened to cover a wide range of behaviours and harms, including those related to alcohol, tobacco and recreational drug use. Part III addresses challenges and innovations and the requirement to integrate and match interventions to individual and social needs.
See next edition of Drugnet Europe for full coverage.
Available in English at www.emcdda.europa.eu/publications/monographs/harm-reduction
EMCDDA website survey results
The EMCDDA has recently analysed responses received via a three-month user survey of its website. Through this survey, launched in December 2009, the agency invited visitors to the website to fill in a short questionnaire providing information about themselves and their opinion of the site. Of the respondents, 78 % said they were satisfied with the website. Regarding visitor profiles, the most popular replies were researcher (20 %), government employee (15 %), partner organisation (15 %) and job seeker (15 %). Later this year, the agency will address the issues highlighted through the survey, by reorganising and redesigning certain aspects of the site.
Follow us on Twitter
It is now easier than ever to keep up-to-date with EMCDDA activities by following us on the social networking and microblogging service Twitter. Our regular ‘tweets’ will keep you informed of our latest news as well as other developments on drugs in Europe.
New edition of risk assessment operating guidelines
The EMCDDA published in March a revised version of its operating guidelines for the risk assessment of new psychoactive substances. The guidelines establish a sound methodological and procedural basis for carrying out risk assessments of new drugs entering Europe’s illicit drug market.
Available in English at www.emcdda.europa.eu/publications/risk-assessments
In this issue...
- Record number of new drugs in 2009
- EMCDDA and Europol Directors review new drugs entering market
- EMCDDA and ECDC assess anthrax outbreak among heroin users
- Global audit of HIV services for IDUs reveals low levels of provision
- Sharing information on drug treatment demand in the Mediterranean
- Drug use and pregnancy: challenges for public health
- Enhancing the quality and effectiveness of services for drug users
- Experts debate drug policy
- Latest analysis of cocaine market highlights 'secondary extraction' laboratories in Europe
- EMCDDA active at annual CND meeting
- New pact against drug trafficking
- Reitox Academy focuses on national treatment guidelines
- Topic overview on threshold quantities for drug offences
- Forging ties with North-African neighbours
- Joint report on mephedrone presents case for formal risk assessment
Drugnet Europe is also available in downloadable PDF format, for printing or offline browsing.
Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.
Page last updated: Thursday, 03 June 2010